Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about Anorectic Drug one national sysmposium presently dedicated exclusively to Anorectic Drug. Anorectic Drug or appetite suppressant medications are drugs that promote weight loss by decreasing appetite or increasing the sensation of fullness. These drugs are often referred to as diet pills, and have been developed and marketed to replace amphetamines as appetite suppressants. These anorectic drugs include benzphetamine (Didrex), diethylproprion (Tenuate, Tepanil), fenfluramine (Pondimin), mazindol (Sanorex, Mazanor), phendimetrazine (Bontril, Prelu-2, Plegine) and phentermine (Ionamin, AdipexP).
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Anorectic Drug conference provides the scope for opportunities to learn progressed by international scientists and academicians. Anorectic Drug is also sometimes also called as appetite suppressant which is the science concerned that deals with the causes, prevention, and treatment of obesity. Anorectic Drug conference offers excessive quality content to suit the diverse professional development of these medicines to treat people all over the globe. It is a perfect platform to discuss the current discoveries and developments in the field of Obesity and health complications.
An anorectic agent is one that suppresses or decreases a persons appetite. Stimulants in general have anorectic properties but not all are approved by the FDA for that use. Anorectics stimulate both the beta and dopaminergic receptors in the CNS and we get appetite suppression. In other words, they are beta and dopaminergic agonists.
Anorectic Drug conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of:
1. Appetite suppressant medication
It also provides the platform for researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Appetite suppressants. The recent research in Obesity shares knowledge to scholars pursing their studies in this field.
An anorectic Drug, is a dietary supplement or drug which reduces appetite and food consumption, and, as a result, causes weight loss to occur. These are drugs promote weight loss by decreasing appetite or increasing the sensation of fullness. The anorectic drugs have a very definite part to play in the treatment of obesity, mainly for those individuals who have altered their eating habits but have come to a plateau of weight which they find difficult to get below. The drugs are best given in a long-acting form and can safely be continued as long as weight loss persists, provided that the clinician exercises careful supervision.
These anorectic drugs include :
• Benzphetamine (Didrex®)
• Diethylproprion (Tenuate®)
• Mazindol (Sanorex®, Mazanor®)
• Phendimetrazine (Bontril®, Prelu-27®)
• Andphentermine (Lonamin®,Fastin®,Adipex®)
These substances are in Schedule III or IV of the CSA and produce some amphetamine-like effects. Of these diet pills diet pills, phentermine is the most widely prescribed and most frequently encountered on the illicit market. Two Schedule IV anorectics often used in combination with phentermine (phen-fen combo), fenfluramine and dexfenfluramine, were removed from the U.S. market due to heart valve problems
In 2009, UNODC estimates that, with an annual prevalence ranging between 0.3% and 1.3%, between 13.7 and 56.4 million people aged 15-64 globally had used amphetamines-group (anorectic drug) substances at least once in the past year. While these numbers reflect a slight increase over estimates for previous years, they do not essentially indicate a significant difference in the prevalence of amphetamines-group substances.
3) World Congress on Obesity
August 08-10, 2016 Toronto, Canada
7) World Congress on Public Health & Nutrition
March 10-12, 2016 Madrid, Spain, 2016
8) 6th Endocrinology conference
November 28-30, 2016 Baltimore, USA
9) 11th Exhibition on Targeting Diabetes and Novel Therapeutics
October 17-19, 2016 Kuala Lumpur, Malaysia.
10) Metabolic Syndromes
October 20-22, 2016 Dubai, UAE
11)3rd Global Experts Meeting on Weight Loss and Medicare Expo
September 19-21, 2016 Vienna, Austria.
12) 9th Global Diabetes Summit and Medicare Expo
November 14-16, 2016 Dubai, UAE
13) ICO 2016 : 18th International Conference on Obesity London
May23-24, 2016, United Kingdom
14) The 2016 Obesity Summit
12-14th April 2016, London
15) Emirates Obesity and Metabolic Surgery Interest Group
12 – 14 December 2015, Raffles Hotel Dubai, UAE
16)The XIII International Conference on Obesity
May 1-4, 2016 Vancouver, BC, Canada
17)23rd European Congress on Obesity
Gothenburg, Sweden, June 1–4, 2016
18)Obesity Week 2016
October 31–November 5, 2016, New Orleans, Louisiana, USA
19)Hot Topic Conference: Obesity and Pregnancy
29 - 30 October 2015, London, UK
20)MASO 2015 Scientific Conference on Obesity
Seri Pacific Hotel,28-29 October, 2015, Kuala Lumpur
The British Obesity and Metabolic Surgery Society (BOMSS)
EASO – European Association for the study of Obesity
British Obesity Society
American Society for Bariatric Surgeons
IDEA Health & Fitness Association
Aston Aerial Fitness Society
National Obesity Forum
NHLBI obesity research
Office of Dietary Supplements (ODS)
JASSO Japan Society for the Study of Obesity
American Heart Association
The Nutrition Society (NS)
Phillipine Association for the study of Obesity
The American Society for Metabolic and Bariatric Surgery (ASMBS)
European Society of Endocrinology and Obesity
American Sports and Fitness Asociation (ASFA)
European Fitness Association (EFA)
Aerobics and Fitness Association of America (AFAA)
The European Health and Fitness Association (EHFA)
American Association For Clinical Endocrinologists (AACE)
M Pharmaceutical Inc.
Arena Pharmaceuticals Inc.
Orexigen Therapeutics, Inc.
This page will be updated regularly.
This page was last updated on April 10, 2020